腹主动脉瘤腔内修复术后早期与晚期Ib型内漏的危险因素
该回顾性病例对照研究纳入383例患者共635条髂支,比较早期与晚期Ib型内漏(T1bEL)的解剖、人口学和技术因素。总体T1bEL发生率为3.5%(22/635),早期和晚期各11条。多变量分析显示早期T1bEL与髂总动脉(CIA)迂曲、短CIA和短远端密封长度相关,晚期T1bEL与较大瘤囊直径、短CIA和短远端密封长度相关。
要点
- 早期T1bEL危险因素:CIA迂曲、CIA短、远端密封长度短。
- 晚期T1bEL危险因素:瘤囊最大直径大、CIA短、远端密封长度短。
- 充分密封长度可能对T1bEL有保护作用,尤其瘤囊大或CIA高危时。
核心结论
- T1bEL的发生机制随术后时间不同而异。
- 充分的密封长度可能对T1bEL具有保护作用。
研究设计与样本
- 回顾性病例对照研究,基于前瞻性维护数据库。
- 纳入383例患者共635条髂支,T1bEL组22条(早期11条、晚期11条)。
主要发现
- 总体T1bEL发生率为3.5%(22/635),早期和晚期各11条。
- 早期T1bEL组CIA更迂曲(P=0.02)、CIA更短(P=0.04)、远端密封长度更短(P=0.03)。
- 晚期T1bEL组瘤囊最大直径更大(P<0.001)、CIA更短(P=0.02)、远端密封长度更短(P=0.002)。
- 晚期T1bEL发生的中位随访时间为44(32-82)个月,短于晚期对照组(P=0.03)。
- 性别、年龄和支架品牌在T1bEL组与对照组间无显著差异。
关键数值与推荐
- 早期T1bEL定义为EVAR术后6个月内发生的T1bEL。
- 晚期T1bEL定义为EVAR术后超过6个月首次发现的T1bEL。
- 除1例主动脉夹层患者外,T1bEL均采用髂支延长治疗。
临床怎么用
- 术前应仔细评估腹主动脉瘤大小以及CIA长度和迂曲度。
- 对具有高危特征的患者应进行严格的术后监测。
- 对瘤囊大或CIA高危(大直径或短长度)者,应考虑更长的密封长度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: A type Ib endoleak (T1bEL) is a postoperative complication that usually requires additional interventions following endovascular aortic aneurysm repair. Previous studies have focused on iliac artery tortuosity or common iliac artery (CIA) diameter. However, we investigated the various risk factors for early and late T1bELs more comprehensively. METHODS: This retrospective case-control study of a prospectively maintained database compared anatomical, demographic and technical factors between patients with early or late T1bELs and a control group. Early T1bEL was defined as a T1bEL occurring within 6 months of endovascular aneurysm repair (EVAR), while late T1bEL was defined as a T1bEL, initially identified more than 6 months after EVAR. Anatomical values including neck diameter, length, and angle; maximum sac diameter and length; CIA length, diameter, and tortuosity; and distal sealing length were measured and included in the analysis. We performed uni- and multivariable analyses using logistic regression and Cox proportional hazard models. RESULTS: This study included 635 iliac limbs of 383 patients. Overall, T1bELs occurred in 22 iliac limbs during the follow-up period (22/635, 3.5%). Among them, the early and late T1bEL groups each included 11 limbs. The median follow-up duration of the 383 patients was 23 (8-58) months, and in the early T1bEL and early control groups, the durations were 15 (9-35) and 29 (15-60) months, respectively (P = 0.01). The median overall follow-up durations in the late T1bEL and late control groups were 87 (76-102) and 62 (48-80) months, respectively (P = 0.01). The median follow-up duration until the occurrence of late T1bEL was 44 (32-82) months, which was shorter than that of the late control group (P = 0.03). No significant differences in sex, age, or brand of stent-graft were observed between the T1bEL and control groups. In the multivariable analysis, patients in the early T1bEL group had significantly more tortuous and short CIAs, and short distal sealing lengths (P = 0.02, P = 0.04, P = 0.03, respectively), and the late T1bEL group had significantly larger maximum aortic aneurysm sac diameters, short CIAs and short distal sealing lengths (P < 0.001, P = 0.02, P = 0.002, respectively). The suspected mechanisms of the T1bELs were CIA dilatation with or without sac expansion and aggravation of sac angulation. Except for one patient with aortic dissection, T1bELs were treated with iliac limb extensions. CONCLUSIONS: The various mechanisms of T1bELs differed depending on the time of onset from the procedure. An extensive sealing length may be protective against T1bEL, especially when the size of the aortic aneurysm sac is large or when the CIA has risky features, including large diameter or short length. Careful preoperative consideration of aortic aneurysm size and CIA length and tortuosity is essential, and patients with risky features should undergo strict postoperative surveillance.
引用
- Choi E, Lee SA, Ko GY, et al. Risk Factors for Early and Late Type Ib Endoleak Following Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2020. PMID: 32927037. doi:10.1016/j.avsg.2020.08.144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。